Mazyar Shadman, MD, MPH

Mazyar Shadman, MD, MPH

Mazyar Shadman, MD, MPH

Articles by Mazyar Shadman, MD, MPH

Mazyar Shadman, MD, MPHThe HemOnc Pulse | September 27, 2024
Dr. Shadman, of the Fred Hutchinson Cancer Center, shares CLL news from the SOHO 2024 Annual Meeting.
Listen Now
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse Live | August 22, 2024
Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD continue their discussion on MRD in CLL during HOP Live 2024.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse Live | September 3, 2024
This episode explores questions in CLL with Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD during HOP Live 2024.
Mazyar Shadman, MD, MPHChronic Lymphocytic Leukemia | June 12, 2024
The study utilized three clinical trials to compare the efficacy of acalabrutinib, zanubrutinib, and ibrutinib for CLL.